Lead: Clinical Trials

4 trials of Lead, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Completed 4
Phase 12Completed 2

Follow Lead: new trials by email Literature Review of Lead trials Research Report on Lead

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM)
Pembrolizumab at 7 days prior, Pembrolizumab at 14 days post, Pembrolizumab at 35 days post - Glioblastoma, Adult
Phase 1 / Phase 2CompletedCase Comprehensive Cancer Center322017-11-292026-09-17
Atu027 Plus Gemcitabine in Advanced or Metastatic Pancreatic Cancer (Atu027-I-02)
Atu027 & gemcitabine in lead in safety period, Atu027 & gemcitabine in treatment arm 1, Atu027 & gemcitabine in treatment arm 2 - Carcinoma, Pancreatic Ductal
Phase 1 / Phase 2CompletedSilence Therapeutics GmbH292013-03-012016-03-11
Swallowing Intervention During Radiochemotherapy on Head and Neck Cancer
pre, during and pos-treatment swallowing exercises - Head Neck Cancer, Swallowing Disorders
Phase 2CompletedBarretos Cancer Hospital942012-07-012017-06-28
Vitamin E for Oxaliplatin-induced Peripheral Neuropathy Prophylaxis
Vitamin E, Placebo - Peripheral Neuropathy
Phase 2CompletedFelipe Melo Cruz382009-08-012012-02-01

Conditions studied

Adenocarcinoma (1)  ·  Brain Neoplasms (1)  ·  Carcinoma, Pancreatic Ductal (1)  ·  Communication Disorders (1)  ·  Deglutition Disorders (1)  ·  Glioblastoma (1)  ·  Head and Neck Neoplasms (1)  ·  Peripheral Nervous System Diseases (1)

Sponsors

Barretos Cancer Hospital (1)  ·  Case Comprehensive Cancer Center (1)  ·  Felipe Melo Cruz (1)  ·  Silence Therapeutics GmbH (1)

Countries

Brazil (2)  ·  Germany (1)  ·  United States (1)

Top investigators

Alexandre Jacinto, MD (1)  ·  Auro del Giglio, phD (1)  ·  Dirk Strumberg, Prof.Dr.med. (1)  ·  Juliana Portas, MSC (1)  ·  Luciano S Viana, PHD (1)  ·  Tiffany Hodges, MD (1)

Results publications

PMID 23538593, PMID 33114652